Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.
Similar Posts
Access, new active substance and biosimilar work sharing initiatives
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
Decision: Orphan registered medicinal products
A list of authorised orphan medicinal products registered by the UK licensing authority.
CDERLearn
Training and Education for healthcare professionals, academia, and consumers from FDA’s Center for Drug Evaluation and Research
M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol
M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol
Infusion Pump Correction: Baxter Updates Instructions for Use for Novum IQ Large Volume Pump due to Potential for Underinfusion
Infusion Pump Correction: Baxter Issues Correction for Novum IQ Large Volume Pump due to Potential for Underinfusion
2023 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee
This page contains the meeting materials for the Cardiovascular & Renal Drugs Advisory Committee meetings for 2023.